文献速递复苏、休克与脓毒症呼吸衰竭与机械通气重症综合管理与镇静镇痛

液体负荷对接受气管插管的危重患者心血管虚脱的影响:一项随机临床试验

Effect of Fluid Bolus Administration on Cardiovascular Collapse Among Critically Ill Patients Undergoing Tracheal Intubation: A Randomized Clinical Trial.
PubMed 文献 · JAMA · 2022-01-01
一句话结论危重成人气管插管时给予500 mL静脉液体负荷未显著降低心血管虚脱发生率(21.0% vs 18.2%,P=0.25)。

该随机临床试验纳入美国11个ICU的1067例接受气管插管、镇静和正压通气的危重成人,随机分为500 mL静脉液体负荷组(n=538)和无液体负荷组(n=527)。主要终点心血管虚脱(麻醉诱导至插管后2分钟内新发或增加血管升压药使用或收缩压<65 mm Hg,或诱导至插管后1小时内心脏骤停或死亡)发生率液体负荷组为21.0%,无液体负荷组为18.2%(绝对差异2.8%,95%CI -2.2%至7.7%;P=0.25)。28天前死亡(出院时删失)发生率液体负荷组40.5%,无液体负荷组42.3%(绝对差异-1.8%,95%CI -7.9%至4.3%;P=0.55)。结论认为液体负荷未显著降低心血管虚脱发生率。

要点

  • 危重成人气管插管时给予500 mL静脉液体负荷,心血管虚脱发生率为21.0%,未液体负荷组为18.2%,绝对差异2.8%(95%CI -2.2%至7.7%;P=0.25),未达统计学显著。
  • 新发或增加血管升压药使用率液体负荷组20.6%,无液体负荷组17.6%;收缩压<65 mm Hg发生率分别为3.9%和4.2%。
  • 心脏骤停发生率液体负荷组1.7%,无液体负荷组1.5%;插管后1小时内死亡发生率分别为0.7%和0.6%。
  • 28天前死亡(出院时删失)液体负荷组40.5%,无液体负荷组42.3%,绝对差异-1.8%(95%CI -7.9%至4.3%;P=0.55)。

适用人群与场景

  • 美国11个ICU中接受气管插管、镇静和正压通气的危重成人,年龄中位数62岁(IQR 51-70岁),42.1%为女性。

诊断标准与关键阈值

  • 心血管虚脱定义:麻醉诱导至气管插管后2分钟内新发或增加血管升压药使用,或收缩压<65 mm Hg;或麻醉诱导至气管插管后1小时内发生心脏骤停或死亡。

处置流程与药物剂量

  • 干预组在气管插管前给予500 mL静脉液体负荷,对照组不予液体负荷。

研究设计与关键结果

  • 随机临床试验,纳入1067例患者,随机分为液体负荷组(n=538)和无液体负荷组(n=527);1065例(99.8%)完成试验并纳入主要分析。
  • 主要终点心血管虚脱发生率:液体负荷组21.0%(113例) vs 无液体负荷组18.2%(96例),绝对差异2.8%(95%CI -2.2%至7.7%;P=0.25)。
  • 新发或增加血管升压药使用率:液体负荷组20.6% vs 无液体负荷组17.6%;收缩压<65 mm Hg发生率:3.9% vs 4.2%;心脏骤停发生率:1.7% vs 1.5%;插管后1小时内死亡发生率:0.7% vs 0.6%。
  • 28天前死亡(出院时删失)发生率:液体负荷组40.5%(218例) vs 无液体负荷组42.3%(223例),绝对差异-1.8%(95%CI -7.9%至4.3%;P=0.55)。

证据类型、等级与局限

  • 证据类型:随机临床试验(RCT)。
  • 局限:原文未报告局限性。

对床旁实践的改变

  • 对于接受气管插管的危重成人,静脉液体负荷相比无液体负荷未显著降低心血管虚脱发生率,不支持为预防心血管虚脱而常规给予液体负荷。

提炼说明

  • 本条依据论文摘要整理;摘要未涉及「红旗征与不能漏的情况」「指南或共识出处」,故未列出这些栏目;全文请点「阅读原文」。
英文原文(摘要)· 点击展开

IMPORTANCE: Hypotension is common during tracheal intubation of critically ill adults and increases the risk of cardiac arrest and death. Whether administering an intravenous fluid bolus to critically ill adults undergoing tracheal intubation prevents severe hypotension, cardiac arrest, or death remains uncertain.

OBJECTIVE: To determine the effect of fluid bolus administration on the incidence of severe hypotension, cardiac arrest, and death.

DESIGN, SETTING, AND PARTICIPANTS: This randomized clinical trial enrolled 1067 critically ill adults undergoing tracheal intubation with sedation and positive pressure ventilation at 11 intensive care units in the US between February 1, 2019, and May 24, 2021. The date of final follow-up was June 21, 2021.

INTERVENTIONS: Patients were randomly assigned to receive either a 500-mL intravenous fluid bolus (n = 538) or no fluid bolus (n = 527).

MAIN OUTCOMES AND MEASURES: The primary outcome was cardiovascular collapse (defined as new or increased receipt of vasopressors or a systolic blood pressure <65 mm Hg between induction of anesthesia and 2 minutes after tracheal intubation, or cardiac arrest or death between induction of anesthesia and 1 hour after tracheal intubation). The secondary outcome was the incidence of death prior to day 28, which was censored at hospital discharge.

RESULTS: Among 1067 patients randomized, 1065 (99.8%) completed the trial and were included in the primary analysis (median age, 62 years [IQR, 51-70 years]; 42.1% were women). Cardiovascular collapse occurred in 113 patients (21.0%) in the fluid bolus group and in 96 patients (18.2%) in the no fluid bolus group (absolute difference, 2.8% [95% CI, -2.2% to 7.7%]; P = .25). New or increased receipt of vasopressors occurred in 20.6% of patients in the fluid bolus group compared with 17.6% of patients in the no fluid bolus group, a systolic blood pressure of less than 65 mm Hg occurred in 3.9% vs 4.2%, respectively, cardiac arrest occurred in 1.7% vs 1.5%, and death occurred in 0.7% vs 0.6%. Death prior to day 28 (censored at hospital discharge) occurred in 218 patients (40.5%) in the fluid bolus group compared with 223 patients (42.3%) in the no fluid bolus group (absolute difference, -1.8% [95% CI, -7.9% to 4.3%]; P = .55).

CONCLUSIONS AND RELEVANCE: Among critically ill adults undergoing tracheal intubation, administration of an intravenous fluid bolus compared with no fluid bolus did not significantly decrease the incidence of cardiovascular collapse.

TRIAL REGISTRATION: ClinicalTrials.gov Identifier: NCT03787732.

来源:JAMA,查看原文。版权归原作者所有。

参考来源

  1. Russell DW, Casey JD, Gibbs KW, et al. Effect of Fluid Bolus Administration on Cardiovascular Collapse Among Critically Ill Patients Undergoing Tracheal Intubation: A Randomized Clinical Trial. JAMA. 2022. PMID: 35707974. doi:10.1001/jama.2022.9792

供执业医师抢救与诊疗参考,不替代临床判断;剂量请结合体重、肝肾功能和本院药品规格复核,以指南原文为准。